Moderna to seek U.S. and EU authorization for its vaccine
NEW DELHI: Moderna has announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196...
NEW DELHI: Moderna has announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196...